Although the NFT density can correlate with the degree of AD progression (Lee et al., 2011; Ballatore et al., 2007; Morris et al., 2011), soluble tau protein levels are more closely linked to disease progression and cognitive decline (Götz et al., 2008; Koss et al., 2016). The gene discussed is MAPT; the disease is Alzheimer disease.